By making intentional food choices, adjusting physical activities, and staying mindful of mental health, individuals can ...

The following is a summary of “Surgery versus non-surgical treatment for endometriosis-related pain during the COVID-19 ...

Visanne, also known by the generic name dienogest, will have its cost reduced from more than $800 per year for a course of ...

Endometriosis is a complex condition that affects millions of individuals worldwide Characterized by the growth of endometrial-like tissue outside the uterus this condition can lead to debilitating pa ...

Visanne is officially the first endometriosis treatment medication to be subsidised by the government in 30 years, more than ...

The market for endometriosis treatment is projected to attain a value of US$ 3.1 billion by 2034. According to Transparency ...

The daily tablet can help reduce pain and inflammation caused by the chronic and often debilitating condition.

For the 1 in 7 women affected by endometriosis, the news of a government subsidised treatment drug could be life-changing.

People living with endometriosis will now have easier access to treatment after dienogest was added to the Pharmaceutical Benefits Scheme.

“Our Government’s listing of Visanne on the PBS will be a game changer for women living with endo. Making this medicine ...

Girls and women undergoing painful health conditions such as endometriosis and heavy menstrual bleeding have had their ...

Despite a cost-of-living crisis, young people aged 25 to 29 have had the biggest take-up of private health insurance over the ...